PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.83%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.74%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-11.58%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-25.27%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-11.81%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 9843.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
44.88%
10Y revenue/share CAGR under 50% of 9843.T's 95.95%. Michael Burry would suspect a lasting competitive disadvantage.
-7.45%
Negative 5Y CAGR while 9843.T stands at 56.99%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
38.84%
3Y revenue/share CAGR similar to 9843.T's 36.33%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
194.01%
Below 50% of 9843.T's 600.53%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
16.46%
Below 50% of 9843.T's 139.71%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
59.57%
3Y net income/share CAGR 50-75% of 9843.T's 100.47%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
131.98%
10Y equity/share CAGR at 50-75% of 9843.T's 182.65%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
27.65%
Below 50% of 9843.T's 116.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.35%
3Y equity/share CAGR 1.25-1.5x 9843.T's 49.73%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
-2.78%
Negative 5Y dividend/share CAGR while 9843.T stands at 127827.33%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-30.00%
Negative near-term dividend growth while 9843.T invests at 55.56%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-12.20%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.37%
We show growth while 9843.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.87%
Asset growth at 50-75% of 9843.T's 2.57%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.11%
BV/share growth above 1.5x 9843.T's 0.25%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.73%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
2.77%
We expand SG&A while 9843.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.